Co-Diagnostics enters senior secured convertible note agreement
Co-Diagnostics, Inc. announced a $2.1 million senior secured convertible note issuance, with principal repayments scheduled in 30 weekly installments starting October 14, 2026. This financing underscores the company's efforts to secure capital despite current market conditions.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed